Manjie Zhang

Manjie Zhang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
KQKezhen Qi
Kezhen Qi
BSBin Sun
Bin Sun
SLShu-yuan Liu
Shu-yuan Liu
MZManjie Zhang
Manjie Zhang
At present, cancer remains one of the leading causes of human death worldwide, and surgery, radiotherapy and chemotherapy are still the main methods of cancer treatment. However, these treatments have their drawbacks. Surgical treatment often struggles with the complete removal of tumor tissue, leading to a high risk of cancer recurrence. Additionally, chemotherapy drugs have a significant impact on overall health and can easily result in drug resistance. The high risk and mortality of cancer and other reasons promote scientific researchers to unremittingly develop and find a more accurate and faster diagnosis strategy and effective cancer treatment method. Photothermal therapy, which utilizes near-infrared light, offers deeper tissue penetration and minimal damage to surrounding healthy tissues. Compared to conventional radiotherapy and other treatment methods, photothermal therapy boasts several advantages, including high efficiency, non-invasiveness, simplicity, minimal toxicity, and fewer side effects. Photothermal nanomaterials can be categorized as either organic or inorganic materials. This review primarily focuses on the behavior of carbon materials as inorganic materials and their role in tumor photothermal treatment. Furthermore, the challenges faced by carbon materials in photothermal treatment are discussed.

24 January 2025 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
XPXiang Pan
Xiang Pan
KCKailai Chen
Kailai Chen
WGWei Gao
Wei Gao
MXMeiqi Xu
Meiqi Xu
FMFanlong Meng
Fanlong Meng
YLYAKUN LUO
YAKUN LUO
Metastasis is a leading cause of cancer-related death in castration-resistant prostate cancer (CRPC) patients. Circular RNAs (circRNAs) have emerged as key regulators of the metastasis of various cancers. However, the functional effects and regulatory mechanisms of circRNAs in metastatic CRPC (mCRPC) remain largely unknown. The expression of circBNC2 in prostate cancer (PCa), CRPC and neuroendocrine prostate cancer (NEPC) tissues was analyzed through bioinformatics analysis. Functional assays, including cell proliferation, migration, invasion and ferroptosis, were conducted in vitro and in vivo. The interactions between circBNC2, miR-4298, and ACSL6 were explored via luciferase reporter assays, RNA immunoprecipitation, and western blotting analysis. In addition, for the first time in PCa, we developed novel nanobowls (NBs) loaded with docetaxel (DTX) and circBNC2 (Dc-NBs) and evaluated the antitumor efficacy of Dc-NBs in a photothermal therapy (PTT) strategy. We identified a novel tumor-suppressive circRNA, circBNC2, in human PCa, CRPC and NEPC samples via bioinformatic analysis. CircBNC2 expression was significantly downregulated in PCa tissues and PCa cell lines. Functional assays demonstrated that circBNC2 inhibited PCa cell proliferation and migration both in vitro and in vivo. Mechanistically, circBNC2 acted as a sponge for miR-4298, and ACSL6 was identified as a direct target of the circBNC2/miR-4298 axis. Moreover, we demonstrated that ACSL6 is essential for mediating circBNC2-regulated ferroptosis in PCa cells. More importantly, we demonstrated the nanodelivery of Dc-NBs, which exhibited significant antitumor effects in both subcutaneous and metastatic PCa models. This study revealed the tumor-suppressive role of circBNC2 in mCRPC by driving ferroptosis via the circBNC2/miR-4298/ACSL6 axis. Additionally, we developed an efficient and safe PTT strategy based on a nanodelivery system that codelivers circBNC2 and DTX, highlighting its potential as a novel therapeutic approach for mCRPC.

28 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
QSQing Shi
Qing Shi
MXMeiqi Xu
Meiqi Xu
ZKZhijian Kang
Zhijian Kang
MZManjie Zhang
Manjie Zhang
YLYAKUN LUO
YAKUN LUO
Encoded by the MEN1 gene, menin protein is a fusion protein that is essential for the oncogenic transformation of mixed-lineage leukemia (MLL) and leads to acute leukemia (AL). Therefore, accumulating evidence has demonstrated that inhibition of the high-affinity relationship between menin and mixed-lineage leukemia 1 (MLL1 and KMT2A) is an effective treatment for MLL-rearranged (MLL-r) leukemia in vitro and in vivo. Meanwhile, recent studies found that menin–MLL1 interaction inhibitors exhibited a firm tumor suppressive ability in specific cancer cells, such as prostate cancer, breast cancer, liver cancer, and lung cancer. Overall, it seems to serve as a novel therapeutic means for cancers. Herein, we review the recent progress in exploring the inhibitors of small molecule menin–MLL1 interactions. The molecular mechanisms of these inhibitors’ functions and their application prospects in the treatment of AL and cancers are explored.

24 October 2024 in Biomaterials
Verified
Journal Article
Closed access
BSBin Sun
Bin Sun
WGWei Gao
Wei Gao
XYXinyuan Yu
Xinyuan Yu
CZChunpeng Zhang
Chunpeng Zhang
HDHaoyang Du
Haoyang Du
MZManjie Zhang
Manjie Zhang

23 August 2024 in Acta Biomaterialia
Verified
Journal Article
Closed access
WGWei Gao
Wei Gao
XYXinyuan Yu
Xinyuan Yu
CZChunpeng Zhang
Chunpeng Zhang
HDHaoyang Du
Haoyang Du
SYShiya Yang
Shiya Yang
MZManjie Zhang
Manjie Zhang

13 March 2026 in Biomaterials
Verified
Journal Article
Closed access
HCHang Chi
Hang Chi
CZChunpeng Zhang
Chunpeng Zhang
XPXinyu Pang
Xinyu Pang
MHMengying Han
Mengying Han
FZFujuan Zhang
Fujuan Zhang
MZManjie Zhang
Manjie Zhang